Literature DB >> 1308566

Trypanosoma cruzi: effect of phenothiazines on the parasite and its interaction with host cells.

S L De Castro1, M N Soeiro, M de N De Meirelles.   

Abstract

Phenothiazines were observed to have a direct effect on Trypanosoma cruzi and on its in vitro interaction with host cells. They caused lysis of trypomastigotes (50 uM/24 h) and, in axenic medium, dose-dependent inhibition of amastigote and, to a lesser extent, epimastigote proliferation. Treatment of infected peritoneal macrophages with 12.5 uM chlorpromazine or triflupromazine inhibited the infection; this effect was found to be partially reversible if the drugs were removed after 24 h of treatment. At 60 uM, the drugs caused damage to amastigotes interiorized in heart muscle cells. However, the narrow margin of toxicity between antitrypanosomal activity and damage to host cells mitigates against in vivo investigation at the present time. Possible hypotheses for the mechanism of action of phenothiazines are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1308566     DOI: 10.1590/s0074-02761992000200007

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  3 in total

1.  Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).

Authors:  Jason M Fritzler; Guan Zhu
Journal:  J Antimicrob Chemother       Date:  2011-12-13       Impact factor: 5.790

2.  Croton cajucara crude extract and isolated terpenes: activity on Trypanosoma cruzi.

Authors:  Monica C O Campos; Kelly Salomão; Denise B Castro-Pinto; Leonor L Leon; Helene S Barbosa; Maria Aparecida M Maciel; Solange L de Castro
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

3.  Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.

Authors:  Joseph D Planer; Matthew A Hulverson; Jennifer A Arif; Ranae M Ranade; Robert Don; Frederick S Buckner
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.